体外诊断 (IVD) 市场：按产品类型、按测试类型、按应用、按最终用户、按地区

2025 年全球体外诊断 (IVD) 市场规模预计为 1,267.3 亿美元，预计到 2032 年将达到 1,970.6 亿美元，2025 年至 2032 年的复合年增长率为 6.5%。

数字。 2025 年体外诊断 (IVD)市场占有率（按地区）

全球体外诊断 (IVD) 市场涉及测试血液、尿液和组织等生物样本以检测疾病。 IVD 技术能够早期发现疾病，有助于及时进行临床介入并改善患者的治疗效果。市场成长的动力包括老年人口的成长、慢性病和感染疾病率的上升以及技术进步导致更准确的就地检验和分子诊断测试的发展。然而，一些国家对新产品核可的严格规定和不利的医疗改革阻碍了市场的成长。

市场动态：

全球体外诊断（IVD）市场的发展受到人口老化（他们更容易患慢性疾病）、癌症和糖尿病等文明病发病率上升以及人们对早期发现疾病的认识不断提高的推动。技术进步促进了用于照护现场和家庭检测的微型化和可携式诊断平台的开发，这也是一个主要驱动因素。然而，部分地区对新产品核准的严格监管准则和医疗保险的缩减对市场成长构成了威胁。此外，各国对先进分子诊断测试的报销政策各不相同，限制了市场的成长。新兴国家不断增长的医疗支出带来了丰厚的利润机会。

本研究的主要特点

• 本报告对全球体外诊断 (IVD) 市场进行了详细分析，并以 2024 年为基准年，展示了预测期 (2025-2032) 的市场规模和復合年增长率。
• 它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
• 本报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球体外诊断（IVD）市场的主要企业。
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球体外诊断（IVD）药品市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球体外诊断（IVD）市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 市场机会
• 影响分析
• 市场趋势
• 最新动态
• 收购和合作场景
• 技术概述
• PEST分析

4. 全球体外诊断 (IVD) 市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 对需求和供给的影响
• COVID-19 市场影响

5. 2020 年至 2032 年全球体外诊断 (IVD) 市场（依产品划分）

• 试剂和套件
• 装置

6. 2020 年至 2032 年全球体外诊断 (IVD) 市场按测试类型划分

• 临床化学
• 免疫检测
• 血液学
• 分子诊断
• 微生物学
• 凝血
• 其他的

7. 全球体外诊断 (IVD) 市场，按应用，2020 年至 2032 年

• 感染疾病
• 糖尿病
• 肿瘤学
• 心臟病学
• 肾臟科
• 自体免疫疾病
• 其他的

8. 全球体外诊断 (IVD) 市场，依最终用户划分，2020 年至 2032 年

• 医院和诊所
• 诊断实验室
• 学术研究所
• 其他的

9. 2020 年至 2032 年全球体外诊断 (IVD) 市场（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• Siemens Healthineers
• Sysmex Corporation
• Bio-Rad Laboratories
• bioMerieux SA
• Becton Dickinson, and Company
• Danaher Corporation
• Abbott Laboratories
• F. Hoffmann-la Roche Ltd
• QIAGEN NV
• Arkray, Inc.
• Nittobo Medical Co., Ltd.
• Medical & Biological Laboratories Co., Ltd.
• Miraca Holdings Inc.
• Mizuho Medy Co., Ltd.
• Thermo Fischer Scientific Inc
• Diasorin
• Agilent Technologies, Inc
• Grifols SA
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global In Vitro Diagnostics Ivd Market is estimated to be valued at USD 126.73 Bn in 2025 and is expected to reach USD 197.06 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Figure. In Vitro Diagnostics Ivd Market Share (%), By Region 2025

Global in-vitro diagnostics market involves the testing of biological samples such as blood, urine, tissues, and others for detection of diseases. IVD technologies allow early detection of diseases which helps in timely clinical intervention and improved patient outcomes. The market growth is driven by rising geriatric population, increasing prevalence of chronic and infectious diseases, technological advancements leading to development of more accurate point-of-care and molecular diagnostic tests. However, stringent regulations for new product approvals and unfavorable healthcare reforms in some countries hinders the market growth.

Market Dynamics:

Global in-vitro diagnostics market growth is driven by rising geriatric population who are more prone to chronic diseases, increasing incidence of lifestyle diseases such as cancer and diabetes, and growing awareness regarding early disease detection. Technological advancements have led to the development of miniaturized and portable diagnostic platforms for point-of-care and home-based testing, which is another major growth driver. However, stringent regulatory guidelines for approval of new diagnostic products and reduced healthcare coverage in some regions pose threat to the market growth. Furthermore, reimbursement policies for advanced molecular diagnostic tests vary across countries which restrains the market growth. Growing healthcare expenditure in emerging nations offers lucrative opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global in-vitro diagnostics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global in-vitro diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMerieux S.A., Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray Inc., Nittobo Medical Co. , Medical & Biological Laboratories Co. Ltd., Miraca Holdings Inc., Mizuho Medy Co. Ltd., Thermo Fischer Scientific Inc, Diasorin, Agilent Technologies, Inc, and Grifols SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market.

Market Segmentation

• Product Type:
  • Reagents & Kits
  • Instruments
• Test Type:
  • Clinical Chemistry
  • Immunoassay
  • Hematology
  • Molecular Diagnostics
  • Microbiology
  • Coagulation & Hemostasis Urinalysis
  • Others
• Application:
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disorders
  • Others
• End User:
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Siemens Healthineers
  • Sysmex Corporation
  • Bio-Rad Laboratories
  • bioMerieux S.A.
  • Becton Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Hoffmann-la Roche Ltd
  • QIAGEN N.V.
  • Arkray Inc.
  • Nittobo Medical Co.
  • Medical & Biological Laboratories Co.
  • Miraca Holdings Inc.
  • Mizuho Medy Co. Ltd.
  • Thermo Fischer Scientific Inc
  • Diasorin
  • Agilent Technologies, Inc
  • Grifols SA

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Test Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• PEST Analysis

4. Global In-Vitro Diagnostics Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global In-Vitro Diagnostics Market, By Product, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Reagents & Kits
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Instruments
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global In-Vitro Diagnostics Market, By Test Type, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Clinical Chemistry
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Immunoassay
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hematology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Molecular Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Microbiology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Coagulation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global In-Vitro Diagnostics Market, By Application, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Infectious Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Diabetes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Cardiology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Nephrology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Autoimmune Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global In-Vitro Diagnostics Market, By End User, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global In-Vitro Diagnostics Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sysmex Corporation
• Bio-Rad Laboratories
• bioMerieux S.A.
• Becton Dickinson, and Company
• Danaher Corporation
• Abbott Laboratories
• F. Hoffmann-la Roche Ltd
• QIAGEN N.V.
• Arkray, Inc.
• Nittobo Medical Co., Ltd.
• Medical & Biological Laboratories Co., Ltd.
• Miraca Holdings Inc.
• Mizuho Medy Co., Ltd.
• Thermo Fischer Scientific Inc
• Diasorin
• Agilent Technologies, Inc
• Grifols SA
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact